Document Detail


Anaphylactic reactions during immunotherapy.
MedLine Citation:
PMID:  17493504     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Subcutaneous immunotherapy (IT) with aeroallergen extracts is venerable treatment modality. The major risk associated with IT with commercial aeroallergen extracts is the uncommon occurrence of severe near-fatal or fatal anaphylaxis after injections. The objectives of this article are to review the reported incidences of severe anaphylaxis (near-fatal reactions and fatal reactions), define factors contributing to these events, and identify preventive measures that are likely to reduce or eliminate future fatal and near-fatal anaphylactic events. As with any treatment, anticipated benefits attributed to IT must be weighed against its potential risks.
Authors:
Maziar Rezvani; David I Bernstein
Related Documents :
18820094 - Increased risk of falling in older community-dwelling women with mild cognitive impairm...
18656194 - Epidemiology and outcome of 121 cases of chemical burn in east azarbaijan province, iran.
11269584 - Injuries in mountain biking.
19887164 - Do drivers become less risk-prone after answering a questionnaire on risky driving beha...
2361494 - Seasonal energy deficiency in ethiopian rural women.
11564334 - Male clients of female commercial sex workers: hiv, stds and risk behaviour.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Immunology and allergy clinics of North America     Volume:  27     ISSN:  0889-8561     ISO Abbreviation:  Immunol Allergy Clin North Am     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-05-11     Completed Date:  2007-07-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8805635     Medline TA:  Immunol Allergy Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  295-307, viii     Citation Subset:  IM    
Affiliation:
Division of Allergy/Immunology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0563, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Allergens / adverse effects,  therapeutic use
Anaphylaxis / epidemiology*,  etiology*,  prevention & control*
Desensitization, Immunologic / adverse effects*
Humans
Hypersensitivity / therapy
Incidence
Injections, Subcutaneous
Risk Factors
Chemical
Reg. No./Substance:
0/Allergens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Idiopathic anaphylaxis.
Next Document:  Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations.